AstraZeneca Plans $1.5 Billion Factory in Singapore as Drug Industry Splits From China
AstraZeneca Plc plans to build a $1.5 billion manufacturing facility in Singapore to make antibody-drug conjugates as the U.K. drugmaker pushes to beef up its ability to produce the next-generation…